Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer - Contacts and Locations

Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer

This study is currently recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00059930

Locations


United States, New Jersey
	Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School	Recruiting
	New Brunswick, New Jersey, United States, 08903
	Contact: Clinical Trials Office - Cancer Institute of New Jersey 732-235-8675

United States, New York
	Memorial Sloan-Kettering Cancer Center	Recruiting
	New York, New York, United States, 10021
	Contact: Nancy E. Kemeny, MD 212-639-8068

Sponsors and Collaborators

Memorial Sloan-Kettering Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Nancy E. Kemeny, MD	Memorial Sloan-Kettering Cancer Center